Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.042003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Minkwan Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Yongin Severance Hospital Yonsei University College of Medicine Yongin Gyeonggi-do Republic …. Hauptthemen laut MEDLINE: Atrial Fibrillation, Alcohol Drinking, Fatty Liver, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The recent reclassification of steatotic liver disease into metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction‐associated alcohol‐related liver disease has highlighted their potential cardiovascular implications. This study aimed to investigate the impact of MASLD and metabolic dysfunction‐associated alcohol‐related liver disease on the risk of newly diagnosed atrial fibrillation (AF).
Methods
Data from 362 285 participants who underwent a health screening in 2009 to 2010, sourced from the Korean National Health Insurance database, were identified, and we retrospectively analyzed their data through 2019. Excluding those with other liver diseases and heavy alcoholics, 206 455 participants with a fatty liver index were included. The primary outcome was newly diagnosed AF; associated conditions, such as ischemic stroke and heart failure, were also investigated. Participants were classified into 4 groups based on their steatotic liver disease status and alcohol consumption levels.
Results
Over a median follow‐up of 9.6 years, 5335 participants were newly diagnosed with AF (2.74 per 1000 person‐years). The risk of AF was significantly higher in patients with MASLD who did not consume alcohol (adjusted hazard ratio [aHR], 1.32 [95% CI, 1.23–1.41]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Yongin Severance Hospital Yonsei University College of Medicine Yongin Gyeonggi-do Republic of Korea.
- Department of Physiology Dong-A University College of Medicine Busan Republic of Korea.
- Department of Data Sciences Convergence Dong-A University Interdisciplinary Program Busan Republic of Korea.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine Dong-A University College of Medicine Busan Republic of Korea.
ORCID-Profile: Minkwan Kim, Minkook Son, Sang Yi Moon, Yang Hyun Baek
Zitieren
APA
Kim, M., Son, M., Moon, S. Y., & Baek, Y. H. (2025). Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042003
Vancouver
Kim M, Son M, Moon SY, Baek YH. Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042003
BibTeX
@article{Kim2025,
author = {Kim, Minkwan and Son, Minkook and Moon, Sang Yi and Baek, Yang Hyun},
title = {Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.042003}
}
EUVIMED